Candel Therapeutics (CADL) EBIT (2020 - 2025)
Candel Therapeutics (CADL) reported EBIT of -$15.8 million for Q4 2025, down 93.49% on a YoY basis from -$242.0 million in Q4 2024, and down 19.27% sequentially from -$13.2 million in Q3 2025.
Candel Therapeutics (CADL) EBIT (2020 - 2025) Analysis & Trends
Candel Therapeutics (CADL) has 6 years of EBIT data on file, last reported at -$15.8 million in Q4 2025.
- For the quarter ending Q4 2025, EBIT fell 93.49% year-over-year to -$15.8 million; the trailing twelve-month figure through Dec 2025 stood at -$48.3 million (down 44.63% YoY), and the FY2025 full-year result was -$48.3 million, down 44.63% from the prior year.
- EBIT retreated to -$15.8 million in Q4 2025, from -$13.2 million in the prior quarter.
- In the past five years, EBIT ranged from a high of -$4.7 million in Q1 2021 to a low of -$15.8 million in Q4 2025.
- A 5-year average of -$9.0 million and a median of -$8.8 million in 2022 frame the typical range for EBIT.
- Across the five-year window, EBIT slumped 192.07% in 2021 and advanced 21.1% in 2024, its largest moves.
- Tracing CADL's EBIT over 5 years: stood at -$7.7 million in 2021, then slipped by 4.66% to -$8.1 million in 2022, then fell by 27.37% to -$10.3 million in 2023, then climbed by 21.1% to -$8.1 million in 2024, then plunged by 93.49% to -$15.8 million in 2025.
- Business Quant data shows CADL's EBIT at -$15.8 million in Q4 2025, -$13.2 million in Q3 2025, and -$11.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Candel Therapeutics | 542.51 Mn | 542.51 Mn | - | -15.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -15.75 Mn |
| Sep 30, 2025 | -13.21 Mn |
| Jun 30, 2025 | -11.18 Mn |
| Mar 31, 2025 | -8.13 Mn |
| Dec 31, 2024 | -8.14 Mn |
| Sep 30, 2024 | -8.76 Mn |
| Jun 30, 2024 | -8.57 Mn |
| Mar 31, 2024 | -7.90 Mn |
| Dec 31, 2023 | -10.32 Mn |
| Sep 30, 2023 | -8.86 Mn |
| Jun 30, 2023 | -9.58 Mn |
| Mar 31, 2023 | -9.63 Mn |
| Dec 31, 2022 | -8.10 Mn |
| Sep 30, 2022 | -8.88 Mn |
| Jun 30, 2022 | -8.75 Mn |
| Mar 31, 2022 | -8.99 Mn |
| Dec 31, 2021 | -7.74 Mn |
| Sep 30, 2021 | -8.03 Mn |
| Jun 30, 2021 | -5.30 Mn |
| Mar 31, 2021 | -4.66 Mn |